Senior AI Scientist, Molecular Design - USA Remote
Danaher CorporationFull Time
Senior (5 to 8 years)
Berkeley, California, United States
Key technologies and capabilities for this role
Common questions about this position
This information is not specified in the job description.
This information is not specified in the job description.
The role requires excellent knowledge of medicinal chemistry, expertise in synthetic organic chemistry including planning, synthesis, purification, and characterization of small molecules, and the ability to design novel bioactive molecules and apply principles to improve protein-ligand interactions and DMPK properties.
The company seeks collaborative teammates motivated by its mission and values, emphasizing a highly collaborative interdisciplinary team environment where you report to the VP of Medicinal Chemistry and contribute to the growth of an emerging small molecule therapeutics company.
Strong candidates will have excellent medicinal chemistry knowledge, the ability to independently design and synthesize novel molecules to drive SAR, manage CRO chemists, and communicate results effectively in a collaborative team setting.
Develops therapies for autoimmune diseases
Abata Therapeutics develops therapies for autoimmune diseases, focusing on type 1 diabetes. Their main product, ABA 201, is a Treg cell therapy aimed at patients with some remaining beta cell function. This therapy works by utilizing regulatory T cells to improve patient outcomes. Unlike many competitors, Abata targets a specific niche within the autoimmune disease market and collaborates with partners like ElevateBio for process development and manufacturing. The company's goal is to transform treatment options for autoimmune diseases through advanced research and development.